JO
AGIO icon

John Overdeck’s Agios Pharmaceuticals AGIO Stock Holding History

John Overdeck’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.9M Buy
536,380
+284,744
+113% +$8.64M 0.01% 1059
2026
Q1 		$8.51M Sell
251,636
-48,520
-16% -$1.38M 0.01% 1525
2025
Q4 		$8.17M Buy
300,156
+240,527
+403% +$8.44M 0.01% 1265
2025
Q3 		$2.39M Buy
+59,629
New +$2.24M ﹤0.01% 2011
2025
Q1 		– Sell
-109,373
Closed -$3.59M – 3173
2024
Q4 		$3.59M Buy
+109,373
New +$5.14M 0.01% 1316
2024
Q2 		– Sell
-122,282
Closed -$3.58M – 3001
2024
Q1 		$3.58M Buy
122,282
+76,359
+166% +$2.04M 0.01% 1148
2023
Q4 		$1.02M Buy
+45,923
New +$1.03M ﹤0.01% 2061
2020
Q4 		– Sell
-60,954
Closed -$2.13M – 3293
2020
Q3 		$2.13M Buy
+60,954
New +$2.67M 0.01% 1257
2019
Q4 		– Sell
-113,306
Closed -$3.67M – 3607
2019
Q3 		$3.67M Buy
113,306
+55,866
+97% +$2.31M 0.01% 1035
2019
Q2 		$2.87M Buy
+57,440
New +$3.07M 0.01% 1209
2019
Q1 		– Sell
-230,710
Closed -$10.6M – 2979
2018
Q4 		$10.6M Buy
230,710
+152,792
+196% +$9.43M 0.04% 531
2018
Q3 		$6.01M Sell
77,918
-70,912
-48% -$5.7M 0.02% 867
2018
Q2 		$12.5M Buy
148,830
+13,023
+10% +$1.14M 0.04% 572
2018
Q1 		$11.1M Buy
135,807
+82,542
+155% +$6.38M 0.04% 544
2017
Q4 		$3.04M Buy
53,265
+5,434
+11% +$342K 0.01% 1197
2017
Q3 		$3.19M Buy
+47,831
New +$2.87M 0.01% 1039
2015
Q3 		– Sell
-2,250
Closed -$250K – 2140
2015
Q2 		$250K Buy
+2,250
New +$242K ﹤0.01% 2519

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

John Overdeck's AGIO Position: Q2 2026 in Review

John Overdeck increased its Agios Pharmaceuticals (AGIO) stake by 113% in Q2 2026, buying an estimated $8.64M and bringing the position to 536,380 shares worth $19.9M. The position accounts for 0.01% of the portfolio, ranked #1059.

John Overdeck first reported a position in AGIO in Q2 2015 and has held it in 17 quarters since. 237 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • John Overdeck held 536,380 shares of Agios Pharmaceuticals worth $19.9M as of Q2 2026.
  • John Overdeck bought 284,744 Agios Pharmaceuticals shares in Q2 2026, an estimated $8.64M.
  • Agios Pharmaceuticals made up 0.01% of John Overdeck's portfolio in Q2 2026, its #1059 holding.
  • John Overdeck first reported a position in Agios Pharmaceuticals in Q2 2015 and has held it in 17 quarters since.
  • 237 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.